C.-M. LAI ET AL: "rAAV.sFlt-1 Gene Therapy Achieves Lasting Reversal of Retinal Neovascularization in the Absence of a Strong Immune Response to the Viral Vector", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 50, no. 9, 8 April 2009 (2009-04-08), pages 4279-4287, XP55177071, ISSN: 0146-0404, DOI: 10.1167/iovs.08-3253 (B1)

LAI ET AL: "Long-term Evaluation of AAV-Mediated sFlt-1 Gene Therapy for Ocular Neovascularization in Mice and Monkeys", MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY, ACADEMIC PRESS ; NATURE PUBLISHING GROUP, US, vol. 12, no. 4, 1 October 2005 (2005-10-01), pages 659-668, XP005078445, ISSN: 1525-0016, DOI: 10.1016/J.YMTHE.2005.04.022 (B1)

LALWANI G A ET AL: "A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study", AMERICAN JOURNAL OF OPHTHALMOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 148, no. 1, 1 July 2009 (2009-07-01), pages 43-58.e1, XP026210397, ISSN: 0002-9394, DOI: 10.1016/J.AJO.2009.01.024 [retrieved on 2009-04-18] (B1)

US-A1- 2010 272 719 (B1)

TIMOTHY K MACLACHLAN ET AL: "Preclinical Safety Evaluation of AAV2-sFLT01- A Gene Therapy for Age-related Macular Degeneration", MOLECULAR THERAPY, vol. 19, no. 2, 30 November 2010 (2010-11-30), pages 326-334, XP055136302, ISSN: 1525-0016, DOI: 10.1038/mt.2010.258 (B1)

US National Health Institute: "Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration", Clinical Trials , 16 December 2011 (2011-12-16), XP002751808, Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 01494805/2011_12_16 [retrieved on 2015-12-04] (B1)

US National Institute of Health: "Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)", Clinical Trials , 13 April 2012 (2012-04-13), XP002751809, Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 01024998/2012_04_13 [retrieved on 2015-12-04] (B1)

MICHAEL LUKASON ET AL: "Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule", MOLECULAR THERAPY, vol. 19, no. 2, 26 October 2010 (2010-10-26), pages 260-265, XP055188907, ISSN: 1525-0016, DOI: 10.1038/mt.2010.230 (B1)